A fully remote, asset-light beauty brand specializing in non-toxic professional hair smoothing treatments is available for acquisition in Delray Beach, FL. The company holds a distinctive position in the professional hair care market as a pioneer of chemical-free smoothing formulations, having built a loyal following among salon professionals and end consumers alike. With distribution spanning the United States and several international markets — including Canada, the United Kingdom, the European Union, Australia, and New Zealand — the brand has earned placement in markets that enforce among the toughest cosmetic safety regulations in the world.
The product portfolio centers on a flagship salon smoothing treatment, which drives roughly 80% of revenue, supported by a complementary aftercare line accounting for the balance. Independent third-party testing confirms that all formulations meet strict emissions standards, and the brand maintains regulatory clearance across its international territories. Favorable regulatory trends are working in the company's favor: as lawmakers continue to restrict conventional smoothing chemicals, stylists are migrating toward brands with a verified safe formulation history — a tailwind this company is well-positioned to capture.
The business has achieved meaningful retail scale. It ranks second among smoothing lines on a major professional beauty distribution platform operated by one of the world's largest cosmetics companies, and it is also sold through two of the largest U.S.
e-commerce and mass retail platforms, as well as a premium department store. No single wholesale account represents more than approximately 9% of total revenue, providing strong customer diversification. Direct-to-consumer and e-commerce channels have grown from under 10% to approximately 45% of gross revenue in recent years and carry superior margins relative to wholesale.
Operations are deliberately lean. Two senior employees manage sales and education functions on a day-to-day basis, while customer service, fulfillment, financial administration, and digital marketing are handled by established third-party partners. There is no physical retail or office location.
The overhead structure is minimal, contributing to strong cash flow relative to revenue. A substantial investment in brand development, new product formulation, clinical testing, marketplace onboarding, and regulatory compliance has already been made and expensed. Two additional products are near launch, with two more in active development, providing a near-term revenue ramp that requires no further capital outlay from a buyer.
The company is offered by a financial sponsor seeking an exit after an extended hold period, as the business enters what management views as an accelerating growth phase.